Stegostoma fasciatum isolate 6-17 chromosome 43, sSteFas1.1, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Chondrichthyes; Elasmobranchii; Galeomorphii; Galeoidea; Orectolobiformes; Stegostomatidae; Stegostoma.
REFSEQ INFORMATION: The reference sequence is identical to\nCM039269.1.\nAssembly name: sSteFas1.1\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Squalomix on 2022/02/17. The\noriginal whole-genome shotgun project has the accession\nJAFIRC000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Squalomix\nAssembly Date :: 22-FEB-2021\nAssembly Method :: Platanus v. 1.2.4; P_RNA_scaffolder v.\n commit 7941e0f on May 30, at github;\n 3D-DNA v. 180922\nAssembly Name :: sSteFas1.1\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 95.8x\nSequencing Technology :: Illumina HiSeq\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Stegostoma fasciatum Annotation\n Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: polyA evidence [ECO:0006239]
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
homeobox protein NANOG-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
homeobox protein NANOG-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
homeobox protein NANOG-like, transcript variant X5
homeobox protein NANOG-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
homeobox protein NANOG-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
homeobox protein NANOG-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
homeobox protein NANOG-like, transcript variant X8
homeobox protein NANOG-like, transcript variant X6
homeobox protein NANOG-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon AAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon UAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
ceramide-1-phosphate transfer protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
ceramide-1-phosphate transfer protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
ceramide-1-phosphate transfer protein-like isoform X1
ceramide-1-phosphate transfer protein-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ceramide-1-phosphate transfer protein-like isoform X2
polyunsaturated fatty acid lipoxygenase ALOX15B-like
calmodulin-binding transcription activator 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: calmodulin-binding transcription activator 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
procollagen C-endopeptidase enhancer 2-like
zinc finger MYND domain-containing protein 15-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat and calponin homology domain-containing protein 4-like
stress-associated endoplasmic reticulum protein 2
serrate RNA effector molecule homolog (Arabidopsis)
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
LOW QUALITY PROTEIN: C-type natriuretic peptide 3
potential E3 ubiquitin-protein ligase ariadne-2-like, transcript variant X1
potential E3 ubiquitin-protein ligase ariadne-2-like, transcript variant X2
uncharacterized protein LOC125448829 isoform X1
potential E3 ubiquitin-protein ligase ariadne-2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
T-complex protein 1 subunit theta-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
T-complex protein 1 subunit theta-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
T-complex protein 1 subunit theta-like isoform X1
T-complex protein 1 subunit theta-like isoform X2
very long-chain specific acyl-CoA dehydrogenase, mitochondrial-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: very long-chain specific acyl-CoA dehydrogenase, mitochondrial-like
uncharacterized protein LOC794943 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
sodium/potassium-transporting ATPase subunit beta-2-like isoform X2
sodium/potassium-transporting ATPase subunit beta-2-like isoform X1
sex hormone-binding globulin, transcript variant X1
sex hormone-binding globulin, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125448721, transcript variant X3
uncharacterized LOC125448721, transcript variant X1
uncharacterized LOC125448721, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC125448721 isoform X2
uncharacterized protein LOC125448721 isoform X1
uncharacterized LOC125448721, transcript variant X5
uncharacterized protein LOC125448721 isoform X4
uncharacterized LOC125448721, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
uncharacterized protein LOC125448721 isoform X3
zona pellucida sperm-binding protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
DNA-directed RNA polymerase II subunit RPB1
uncharacterized LOC125448608, transcript variant X4
uncharacterized LOC125448608, transcript variant X1
uncharacterized LOC125448608, transcript variant X2
uncharacterized LOC125448608, transcript variant X3
fragile X mental retardation syndrome-related protein 1-like, transcript variant X3
fragile X mental retardation syndrome-related protein 1-like, transcript variant X2
fragile X mental retardation syndrome-related protein 1-like, transcript variant X1
fragile X mental retardation syndrome-related protein 1-like isoform X3
fragile X mental retardation syndrome-related protein 1-like isoform X2
fragile X mental retardation syndrome-related protein 1-like isoform X1
segment polarity protein dishevelled homolog DVL-2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments
gamma-aminobutyric acid receptor-associated protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cellular tumor antigen p53-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
cellular tumor antigen p53-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
cellular tumor antigen p53-like isoform X1
cellular tumor antigen p53-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
thyroid hormone receptor interactor 6, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
thyroid hormone receptor interactor 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
thyroid hormone receptor interactor 6, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
thyroid hormone receptor interactor 6, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
thyroid hormone receptor interactor 6, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
thyroid hormone receptor interactor 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
lipoma-preferred partner homolog isoform X3
lipoma-preferred partner homolog isoform X2
lipoma-preferred partner homolog isoform X1
lipoma-preferred partner homolog isoform X4
B-cell CLL/lymphoma 6 member B protein-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
B-cell CLL/lymphoma 6 member B protein-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
B-cell CLL/lymphoma 6 member B protein-like
solute carrier family 16 member 13, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
solute carrier family 16 member 13, transcript variant X3
solute carrier family 16 member 13, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 16 member 13, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 16 member 13, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 16 member 13, transcript variant X8
solute carrier family 16 member 13, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 16 member 13, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 16 member 13, transcript variant X1
monocarboxylate transporter 13 isoform X1
solute carrier family 16 member 13, transcript variant X2
solute carrier family 16 member 13, transcript variant X6
solute carrier family 16 member 13, transcript variant X12
solute carrier family 16 member 13, transcript variant X10
solute carrier family 16 member 13, transcript variant X15
solute carrier family 16 member 13, transcript variant X16
solute carrier family 16 member 13, transcript variant X11
monocarboxylate transporter 13 isoform X2
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
arf-GAP with coiled-coil, ANK repeat and PH domain-containing protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
zinc finger HIT domain-containing protein 1
acetylcholinesterase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
acetylcholinesterase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 96% coverage of the annotated genomic feature by RNAseq alignments
very-long-chain 3-oxoacyl-CoA reductase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
eukaryotic translation initiation factor 4E type 2-like
cholinergic receptor, nicotinic, epsilon, transcript variant X2
cholinergic receptor, nicotinic, epsilon, transcript variant X1
acetylcholine receptor subunit epsilon isoform X2
acetylcholine receptor subunit epsilon isoform X1
cholinergic receptor, nicotinic, epsilon, transcript variant X3
acetylcholine receptor subunit epsilon isoform X3
sperm-egg fusion protein TMEM95-like, transcript variant X3
sperm-egg fusion protein TMEM95-like, transcript variant X1
sperm-egg fusion protein TMEM95-like, transcript variant X2
RPA-related protein RADX-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
RPA-related protein RADX-like, transcript variant X2
RPA-related protein RADX-like, transcript variant X3
RPA-related protein RADX-like isoform X1
RPA-related protein RADX-like isoform X2
RPA-related protein RADX-like, transcript variant X4
RPA-related protein RADX-like isoform X3
uncharacterized LOC125448774, transcript variant X2
uncharacterized LOC125448774, transcript variant X1
P2R1A-PPP2R2A-interacting phosphatase regulator 1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
P2R1A-PPP2R2A-interacting phosphatase regulator 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
P2R1A-PPP2R2A-interacting phosphatase regulator 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
P2R1A-PPP2R2A-interacting phosphatase regulator 1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
P2R1A-PPP2R2A-interacting phosphatase regulator 1-like, transcript variant X6
P2R1A-PPP2R2A-interacting phosphatase regulator 1-like isoform X3
P2R1A-PPP2R2A-interacting phosphatase regulator 1-like isoform X2
P2R1A-PPP2R2A-interacting phosphatase regulator 1-like isoform X1
P2R1A-PPP2R2A-interacting phosphatase regulator 1-like isoform X5
P2R1A-PPP2R2A-interacting phosphatase regulator 1-like isoform X6
P2R1A-PPP2R2A-interacting phosphatase regulator 1-like, transcript variant X4
P2R1A-PPP2R2A-interacting phosphatase regulator 1-like isoform X4
P2Y purinoceptor 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
P2Y purinoceptor 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
WD repeat containing, antisense to TP53, transcript variant X4
WD repeat containing, antisense to TP53, transcript variant X2
WD repeat containing, antisense to TP53, transcript variant X5
WD repeat containing, antisense to TP53, transcript variant X1
WD repeat containing, antisense to TP53, transcript variant X3
transmembrane protein 217-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transmembrane protein 217-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
transmembrane protein 217-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
tumor necrosis factor ligand superfamily member 13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
tumor necrosis factor ligand superfamily member 12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
trafficking protein particle complex subunit 1
centrobin, centrosomal BRCA2 interacting protein, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
centrobin, centrosomal BRCA2 interacting protein, transcript variant X2
centrobin, centrosomal BRCA2 interacting protein, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
retinal guanylyl cyclase 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
retinal guanylyl cyclase 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
retinal guanylyl cyclase 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
retinal guanylyl cyclase 2-like, transcript variant X4
retinal guanylyl cyclase 2-like isoform X3
retinal guanylyl cyclase 2-like isoform X1
retinal guanylyl cyclase 2-like isoform X2
galactose-3-O-sulfotransferase 4, transcript variant X3
galactose-3-O-sulfotransferase 4, transcript variant X1
galactose-3-O-sulfotransferase 4, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
TAF6 RNA polymerase II, TATA box binding protein (TBP)-associated factor
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transcription initiation factor TFIID subunit 6
metallo-beta-lactamase domain containing 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
metallo-beta-lactamase domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
metallo-beta-lactamase domain-containing protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
transmembrane protein 272-like, transcript variant X3
transmembrane protein 272-like, transcript variant X5
transmembrane protein 272-like, transcript variant X6
transmembrane protein 272-like, transcript variant X1
transmembrane protein 272-like, transcript variant X4
transmembrane protein 272-like, transcript variant X8
transmembrane protein 272-like, transcript variant X7
transmembrane protein 272-like, transcript variant X9
transmembrane protein 272-like, transcript variant X2
transmembrane protein 272-like isoform X1
transmembrane protein 272-like isoform X2
transmembrane protein 272-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
interferon-induced very large GTPase 1-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 7% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 3 bases at 3 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: interferon-induced very large GTPase 1-like
late endosomal/lysosomal adaptor, MAPK and MTOR activator 4
trafficking protein particle complex subunit 14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 144 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA valine (anticodon CAC); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA lysine (anticodon CUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA leucine (anticodon CAG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
baculoviral IAP repeat-containing protein 1e-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
baculoviral IAP repeat-containing protein 1e-like, transcript variant X2
baculoviral IAP repeat-containing protein 1e-like isoform X1
baculoviral IAP repeat-containing protein 1e-like isoform X2
baculoviral IAP repeat-containing protein 1e-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
baculoviral IAP repeat-containing protein 1e-like isoform X3
baculoviral IAP repeat-containing protein 1-like
baculoviral IAP repeat-containing protein 1g-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
baculoviral IAP repeat-containing protein 1g-like isoform X1
baculoviral IAP repeat-containing protein 1g-like, transcript variant X2
baculoviral IAP repeat-containing protein 1g-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC125448797, transcript variant X3
uncharacterized LOC125448797, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC125448797, transcript variant X1
uncharacterized protein LOC125448797 isoform X3
uncharacterized protein LOC125448797 isoform X2
uncharacterized protein LOC125448797 isoform X1
myeloid protein 1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
myeloid protein 1-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
SPRY domain-containing SOCS box protein 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
diacylglycerol O-acyltransferase 2-like, transcript variant X2
diacylglycerol O-acyltransferase 2-like, transcript variant X3
diacylglycerol O-acyltransferase 2-like, transcript variant X1
monoacylglycerol O-acyltransferase 3a, transcript variant X1
monoacylglycerol O-acyltransferase 3a, transcript variant X2
2-acylglycerol O-acyltransferase 2 isoform X1
2-acylglycerol O-acyltransferase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
proline, glutamate and leucine rich protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
proline-, glutamic acid- and leucine-rich protein 1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1, transcript variant X1
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1, transcript variant X2
AP-1 complex subunit sigma-1A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 46 Proteins, and 81% coverage of the annotated genomic feature by RNAseq alignments
AP-1 complex subunit sigma-1A, transcript variant X1
AP-1 complex subunit sigma-1A isoform X2
AP-1 complex subunit sigma-1A isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
N-acetyltransferase 16, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
N-acetyltransferase 16, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
histidine N-acetyltransferase isoform X1
histidine N-acetyltransferase isoform X2
leucine-rich repeat-containing protein 55-like, transcript variant X3
leucine-rich repeat-containing protein 55-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
leucine-rich repeat-containing protein 55-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
leucine-rich repeat-containing protein 55-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 16% coverage of the annotated genomic feature by RNAseq alignments
chromatin complexes subunit BAP18-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
chromatin complexes subunit BAP18-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
chromatin complexes subunit BAP18-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
chromatin complexes subunit BAP18-like, transcript variant X2
chromatin complexes subunit BAP18-like isoform X2
chromatin complexes subunit BAP18-like isoform X4
chromatin complexes subunit BAP18-like isoform X1
chromatin complexes subunit BAP18-like isoform X3
polyunsaturated fatty acid 5-lipoxygenase-like, transcript variant X2
polyunsaturated fatty acid 5-lipoxygenase-like, transcript variant X1
polyunsaturated fatty acid 5-lipoxygenase-like isoform X1
polyunsaturated fatty acid 5-lipoxygenase-like isoform X2
polyunsaturated fatty acid 5-lipoxygenase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 59% coverage of the annotated genomic feature by RNAseq alignments
GRB10-interacting GYF protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
GRB10-interacting GYF protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
GRB10-interacting GYF protein 2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
GRB10-interacting GYF protein 2-like, transcript variant X3
GRB10-interacting GYF protein 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
GRB10-interacting GYF protein 2-like, transcript variant X7
GRB10-interacting GYF protein 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
GRB10-interacting GYF protein 2-like isoform X1
GRB10-interacting GYF protein 2-like isoform X2
GRB10-interacting GYF protein 2-like isoform X4
GRB10-interacting GYF protein 2-like isoform X6
GRB10-interacting GYF protein 2-like isoform X3
GRB10-interacting GYF protein 2-like isoform X5
uncharacterized LOC125448746, transcript variant X4
uncharacterized LOC125448746, transcript variant X3
uncharacterized LOC125448746, transcript variant X1
uncharacterized LOC125448746, transcript variant X2
UFM1-specific peptidase 1 (non-functional), transcript variant X1
UFM1-specific peptidase 1 (non-functional), transcript variant X4
UFM1-specific peptidase 1 (non-functional), transcript variant X2
UFM1-specific peptidase 1 (non-functional), transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
POP7 homolog, ribonuclease P/MRP subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
POP7 homolog, ribonuclease P/MRP subunit, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
ribonuclease P protein subunit p20 isoform X1
ribonuclease P protein subunit p20 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC125448823, transcript variant X1
uncharacterized LOC125448823, transcript variant X2
uncharacterized LOC125448823, transcript variant X7
uncharacterized LOC125448823, transcript variant X6
uncharacterized LOC125448823, transcript variant X3
uncharacterized LOC125448823, transcript variant X5
uncharacterized LOC125448823, transcript variant X4
uncharacterized LOC125448823, transcript variant X8
uncharacterized LOC125448823, transcript variant X9
uncharacterized protein LOC125448823 isoform X1
uncharacterized protein LOC125448823 isoform X2
uncharacterized protein LOC125448823 isoform X7
uncharacterized protein LOC125448823 isoform X6
uncharacterized protein LOC125448823 isoform X3
uncharacterized protein LOC125448823 isoform X5
uncharacterized protein LOC125448823 isoform X4
uncharacterized protein LOC125448823 isoform X8
uncharacterized protein LOC125448823 isoform X9
solute carrier family 12 member 9, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
solute carrier family 12 member 9, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
solute carrier family 12 member 9 isoform X1
solute carrier family 12 member 9 isoform X2
rho guanine nucleotide exchange factor 15-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
high density lipoprotein binding protein b, transcript variant X3
high density lipoprotein binding protein b, transcript variant X1
high density lipoprotein binding protein b, transcript variant X2
high density lipoprotein binding protein b, transcript variant X7
high density lipoprotein binding protein b, transcript variant X6
high density lipoprotein binding protein b, transcript variant X4
high density lipoprotein binding protein b, transcript variant X5
uncharacterized protein DDB_G0292642-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 23 samples with support for all annotated introns
mitochondrial 2-oxoglutarate/malate carrier protein
leucine-rich repeat-containing protein 15-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
leucine-rich repeat-containing protein 15-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
leucine-rich repeat-containing protein 15-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2, transcript variant X2
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2, transcript variant X3
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2, transcript variant X1
guanine nucleotide-binding protein G(I)/G(S)/G(T) subunit beta-2
multifunctional procollagen lysine hydroxylase and glycosyltransferase LH3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 29 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
acetylcholine receptor subunit beta-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
acetylcholine receptor subunit beta-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
acetylcholine receptor subunit beta-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
acetylcholine receptor subunit beta-like isoform X2
acetylcholine receptor subunit beta-like isoform X1
acetylcholine receptor subunit beta-like isoform X3
acetylcholine receptor subunit beta-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
acetylcholine receptor subunit beta-like isoform X4
protein O-fucosyltransferase 1, transcript variant X1
protein O-fucosyltransferase 1, transcript variant X3
protein O-fucosyltransferase 1, transcript variant X2
GDP-fucose protein O-fucosyltransferase 1
fibroblast growth factor 11-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 54 Proteins, and 70% coverage of the annotated genomic feature by RNAseq alignments
fibroblast growth factor 11-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 64 Proteins, and 88% coverage of the annotated genomic feature by RNAseq alignments
fibroblast growth factor 11-like isoform X2
fibroblast growth factor 11-like isoform X1
nucleotidyltransferase MB21D2-like, transcript variant X5
nucleotidyltransferase MB21D2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nucleotidyltransferase MB21D2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
nucleotidyltransferase MB21D2-like, transcript variant X2
nucleotidyltransferase MB21D2-like, transcript variant X6
nucleotidyltransferase MB21D2-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
nucleotidyltransferase MB21D2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
nucleotidyltransferase MB21D2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nucleotidyltransferase MB21D2-like, transcript variant X10
nucleotidyltransferase MB21D2-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
protein phosphatase 1, regulatory subunit 35, transcript variant X1
protein phosphatase 1, regulatory subunit 35, transcript variant X2
protein phosphatase 1 regulatory subunit 35 isoform X1
protein phosphatase 1 regulatory subunit 35 isoform X2
7SK snRNA methylphosphate capping enzyme-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
zinc finger CW-type PWWP domain protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 70% coverage of the annotated genomic feature by RNAseq alignments
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X1
phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform isoform X2
TSC22 domain family protein 4-like, transcript variant X1
TSC22 domain family protein 4-like, transcript variant X2
TSC22 domain family protein 4-like isoform X1
TSC22 domain family protein 4-like isoform X2
transferrin receptor protein 2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transferrin receptor protein 2-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
transferrin receptor protein 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
transferrin receptor protein 2-like, transcript variant X3
transferrin receptor protein 2-like, transcript variant X4
transferrin receptor protein 2-like isoform X1
transferrin receptor protein 2-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
non-receptor tyrosine-protein kinase TNK1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 85 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
gastrula zinc finger protein XlCGF8.2DB-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
minichromosome maintenance complex component 7
adaptor related protein complex 4 subunit mu 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
transfer RNA glutamine (anticodon UUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 89% coverage of the annotated genomic feature by RNAseq alignments
transfer RNA glutamine (anticodon CUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 66% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 2, facilitated glucose transporter member 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 88 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
probable G-protein coupled receptor 139, transcript variant X1
probable G-protein coupled receptor 139 isoform X1
probable G-protein coupled receptor 139, transcript variant X2
probable G-protein coupled receptor 139 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 39% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
lysophosphatidic acid receptor 6-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
lysophosphatidic acid receptor 6-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lysophosphatidic acid receptor 6-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
lysophosphatidic acid receptor 6-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
lysophosphatidic acid receptor 6-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
lysophosphatidic acid receptor 6-like isoform X1
lysophosphatidic acid receptor 6-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
small nuclear RNA activating complex, polypeptide 2
snRNA-activating protein complex subunit 2
misshapen-like kinase 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
misshapen-like kinase 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
misshapen-like kinase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
misshapen-like kinase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
eukaryotic translation initiation factor 5A-1-like, transcript variant X2
eukaryotic translation initiation factor 5A-1-like, transcript variant X1
eukaryotic translation initiation factor 5A-1-like
neuralized E3 ubiquitin protein ligase 4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
N-alpha-acetyltransferase 38, NatC auxiliary subunit
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
cytochrome b5 domain-containing protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
cytochrome b5 domain-containing protein 1, transcript variant X2
cytochrome b5 domain-containing protein 1 isoform X1
cytochrome b5 domain-containing protein 1 isoform X2
chromodomain helicase DNA binding protein 3, transcript variant X4
chromodomain helicase DNA binding protein 3, transcript variant X1
chromodomain helicase DNA binding protein 3, transcript variant X2
chromodomain helicase DNA binding protein 3, transcript variant X5
chromodomain helicase DNA binding protein 3, transcript variant X6
chromodomain helicase DNA binding protein 3, transcript variant X3
chromodomain helicase DNA binding protein 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
chromodomain helicase DNA binding protein 3, transcript variant X8
chromodomain helicase DNA binding protein 3, transcript variant X9
chromodomain-helicase-DNA-binding protein 3 isoform X1
chromodomain-helicase-DNA-binding protein 3 isoform X8
chromodomain-helicase-DNA-binding protein 3 isoform X4
chromodomain-helicase-DNA-binding protein 3 isoform X2
chromodomain-helicase-DNA-binding protein 3 isoform X5
chromodomain-helicase-DNA-binding protein 3 isoform X6
chromodomain-helicase-DNA-binding protein 3 isoform X9
chromodomain-helicase-DNA-binding protein 3 isoform X3
chromodomain-helicase-DNA-binding protein 3 isoform X7
protein mono-ADP-ribosyltransferase TIPARP-like
voltage-gated potassium channel subunit beta-2-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 52 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 86% coverage of the annotated genomic feature by RNAseq alignments
E3 ubiquitin-protein ligase RNF183-like, transcript variant X2
E3 ubiquitin-protein ligase RNF183-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
E3 ubiquitin-protein ligase RNF183-like isoform X1
E3 ubiquitin-protein ligase RNF183-like isoform X2
RAN guanine nucleotide release factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
RAN guanine nucleotide release factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
arf-GAP domain and FG repeat-containing protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
neuronal tyrosine-phosphorylated phosphoinositide-3-kinase adapter 1
neuroligin-1-like, transcript variant X2
neuroligin-1-like, transcript variant X1
neuroligin-1-like, transcript variant X3
neuroligin-1-like, transcript variant X4
neuroligin-1-like, transcript variant X5
neuroligin-1-like, transcript variant X6
neuroligin-1-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00045